• 검색 결과가 없습니다.

Outcome of Severe Aplastic Anemia Treated with Immunosuppressive Therapy Compared with Bone Marrow Transplantation

N/A
N/A
Protected

Academic year: 2021

Share "Outcome of Severe Aplastic Anemia Treated with Immunosuppressive Therapy Compared with Bone Marrow Transplantation"

Copied!
7
0
0

로드 중.... (전체 텍스트 보기)

전체 글

Loading

수치

Table 1. Patient characteristics
Table 3. Univariate analysis of factors influencing overall  survival
Table 4. Multivariate analysis of factors influencing overall survival

참조

관련 문서

Telavancin versus standard therapy for treatment of complicated skin and skin structure infections caused by gram-positive bacteria: FAST 2 study..

After first field tests, we expect electric passenger drones or eVTOL aircraft (short for electric vertical take-off and landing) to start providing commercial mobility

In this group of high-risk patients with severe COVID-19 pneumonia, treatment with lenzilumab was associated with a significantly shorter time to clinical improvement compared

1 John Owen, Justification by Faith Alone, in The Works of John Owen, ed. John Bolt, trans. Scott Clark, "Do This and Live: Christ's Active Obedience as the

Median overall survival of 28 multiple myeloma patients treated with Cyclophosphamide-Prednisone combination regimens as a primary therapy was 115 weeks.. Median

(2002) Blinded, randomized, multicenter study to evaluate single administration pegfilgrastim once per cycle versus daily filgrastim as an adjunct to chemotherapy in

Consequently, the present study was designed to investigate the effect of adding 60 mg of raloxifene hydrochloride daily to women treated with GnRH-a for severe endometriosis

The clinical outcome and complication for treating proximal femoral shaft fracture were compared and analyzed through the group treated with closed